Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	40.39	-116.04	-194.68
Graham Fair Price	41.33	1.77	1.25
PEG	-57.18	-0.01	0.03
Price/Book	4.23	0.08	0.08
Price/Cash Flow	47.88	-6.25	-11.99
Prices/Earnings	47.88	-1.35	-2.59
Price/Sales	-47.88	0.85	1.64
Price/FCF	47.88	-6.25	-11.99
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	0.25	0.25
Operating Margin	-1.61	-0.08	-0.08
ROA	-100.00	< 0.005	< 0.005
ROE	< 0.005	-0.02	-100.00
ROIC	< 0.005	< 0.005	-109.14
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.07	0.08	-17.90
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	0.89	-1.03	16.59
EPS QOQ	0.82	-1.00	21.72
FCF QOQ	0.75	-1.00	33.34
Revenue QOQ	-0.46	1.00	116.86
Naive Interpretation	member

03 - Financial Growth · Best

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	998.34	499.17	-50.00
Days Sales Outstanding (DSO)	58.19	29.10	-50.00
Inventory Turnover	0.09	0.18	100.00
Debt/Capitalization	0.36	0.34	-5.11
Quick Ratio	0.11	0.11	5.09
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	3.01	3.00	-0.06
Cash	0.09	0.10	10.18
Capex	0.00	0.00	0.00
Free Cash Flow	-0.02	-0.04	-99.88
Revenue	0.15	0.29	99.88
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.82	0.82	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-169.60	-99.50	41.33
Naive Interpretation	Member

06 - Financial Health · Bad

Rating